Back to search results

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Virginia Cancer Institute, Richmond, Virginia, United States

    Contact: Study coordinator (Sue Moore, MSN, RN) · smoore@vacancer.com · 804-287-3000
    Contact: Principal Investigator (Purvi Shah, MD)

  • Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Massey CTO GI Team, RN) · masseygi@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Khalid Matin, MD)

  • VCU Community Memorial Healthcenter, South Hill, Virginia, United States

    Contact: Study coordinator (Massey CTO GI Team) · masseygi@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Khalid Matin, MD)

  • VCU Health Tappahannock Hospital, Tappahannock, Virginia, United States

    Contact: Study coordinator (Massey CTO GI Team) · masseygi@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Khalid Matin, MD)
Study leads

  • Khalid Matin, MD

    Principal Investigator

    Massey Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)